Skip to main content
Journal cover image

ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.

Publication ,  Journal Article
Antonia, SJ; Gettinger, SN; Goldman, J; Brahmer, J; Borghaei, H; Chow, LQ; Ready, NE; Gerber, DE; Juergens, R; Shepherd, F; Laurie, SA; Li, X ...
Published in: J Thorac Oncol
November 2016

Duke Scholars

Published In

J Thorac Oncol

DOI

EISSN

1556-1380

Publication Date

November 2016

Volume

11

Issue

11S

Start / End Page

S250 / S251

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Antonia, S. J., Gettinger, S. N., Goldman, J., Brahmer, J., Borghaei, H., Chow, L. Q., … Hellmann, M. D. (2016). ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology. J Thorac Oncol, 11(11S), S250–S251. https://doi.org/10.1016/j.jtho.2016.09.008
Antonia, Scott J., Scott N. Gettinger, Jonathan Goldman, Julie Brahmer, Hossein Borghaei, Laura Q. Chow, Neal E. Ready, et al. “ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.J Thorac Oncol 11, no. 11S (November 2016): S250–51. https://doi.org/10.1016/j.jtho.2016.09.008.
Antonia SJ, Gettinger SN, Goldman J, Brahmer J, Borghaei H, Chow LQ, et al. ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology. J Thorac Oncol. 2016 Nov;11(11S):S250–1.
Antonia, Scott J., et al. “ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology.J Thorac Oncol, vol. 11, no. 11S, Nov. 2016, pp. S250–51. Pubmed, doi:10.1016/j.jtho.2016.09.008.
Antonia SJ, Gettinger SN, Goldman J, Brahmer J, Borghaei H, Chow LQ, Ready NE, Gerber DE, Juergens R, Shepherd F, Laurie SA, Young T, Geese WJ, Agrawal S, Li X, Hellmann MD. ORAL01.03: CheckMate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced NSCLC: Topic: Medical Oncology. J Thorac Oncol. 2016 Nov;11(11S):S250–S251.
Journal cover image

Published In

J Thorac Oncol

DOI

EISSN

1556-1380

Publication Date

November 2016

Volume

11

Issue

11S

Start / End Page

S250 / S251

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology